Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charis Eng

Showing results (121-130 of 555) with videos related to

Pageof 56
Sort By:
NPJ Genomic Medicine|July 5, 2023
Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndromeTakae Brewer, Lamis Yehia, Peter Bazeley, et al.
European Urology|May 17, 2021
Reply to Eugenio Ventimiglia, Edoardo Pozzi, Massimo Alfano, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Scott D. Lundy, Naseer Sangwan, Neel V. Parekh, et al. Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen Microbiomes in Male Infertility. Eur Urol 2021;79:826-36Scott D Lundy, Sarah C Vij, Charis Eng
Cancer Treatment Reviews|January 30, 2008
Targeted therapy for uveal melanomaPierre L Triozzi, Charis Eng, Arun D Singh
Journal of Cell Science|January 25, 2008
The nuclear affairs of PTENSarah M Planchon, Kristin A Waite, Charis Eng
Neurology|September 9, 2024
Clinical Neurologic Features and Evaluation of PTEN Hamartoma Tumor Syndrome: A Systematic ReviewAndrew Dhawan, Sarah Baitamouni, Darren Liu, et al.
Human Molecular Genetics|February 19, 2013
Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomasYu Wang, Xin He, Qi Yu, et al.
The Oncologist|September 17, 2013
PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?Jessica L Mester, Rebekah A Moore, Charis Eng
American Journal of Human Genetics|August 5, 2022
Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variantsTakae Brewer, Lamis Yehia, Peter Bazeley, et al.
JCO Precision Oncology|July 12, 2021
Interplay Between Class II HLA Genotypes and the Microbiome and Immune Phenotypes in Individuals With PTEN Hamartoma Tumor SyndromeMargaret Jia, Naseer Sangwan, Alice Tzeng, et al.
Human Molecular Genetics|August 26, 2022
Quantitative trait locus (xQTL) approaches identify risk genes and drug targets from human non-coding genomesMarina Bykova, Yuan Hou, Charis Eng, et al.
Pageof 56

Showing results (121-130 of 555) with videos related to

Sort By:
Pageof 56
NPJ Genomic Medicine|July 5, 2023
Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndromeTakae Brewer, Lamis Yehia, Peter Bazeley, et al.
European Urology|May 17, 2021
Reply to Eugenio Ventimiglia, Edoardo Pozzi, Massimo Alfano, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Scott D. Lundy, Naseer Sangwan, Neel V. Parekh, et al. Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen Microbiomes in Male Infertility. Eur Urol 2021;79:826-36Scott D Lundy, Sarah C Vij, Charis Eng
Cancer Treatment Reviews|January 30, 2008
Targeted therapy for uveal melanomaPierre L Triozzi, Charis Eng, Arun D Singh
Journal of Cell Science|January 25, 2008
The nuclear affairs of PTENSarah M Planchon, Kristin A Waite, Charis Eng
Neurology|September 9, 2024
Clinical Neurologic Features and Evaluation of PTEN Hamartoma Tumor Syndrome: A Systematic ReviewAndrew Dhawan, Sarah Baitamouni, Darren Liu, et al.
Human Molecular Genetics|February 19, 2013
Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomasYu Wang, Xin He, Qi Yu, et al.
The Oncologist|September 17, 2013
PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?Jessica L Mester, Rebekah A Moore, Charis Eng
American Journal of Human Genetics|August 5, 2022
Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variantsTakae Brewer, Lamis Yehia, Peter Bazeley, et al.
JCO Precision Oncology|July 12, 2021
Interplay Between Class II HLA Genotypes and the Microbiome and Immune Phenotypes in Individuals With PTEN Hamartoma Tumor SyndromeMargaret Jia, Naseer Sangwan, Alice Tzeng, et al.
Human Molecular Genetics|August 26, 2022
Quantitative trait locus (xQTL) approaches identify risk genes and drug targets from human non-coding genomesMarina Bykova, Yuan Hou, Charis Eng, et al.
Pageof 56